My Ultimate Sign-in System Made Me Invincible Chapter 464 Hands Are Tied (2)

The news reached London during a respectable time of the morning, which somehow intensified the impact.

No one had to rush from their beds or fumble through shocking updates on their phones in the dim light. Those who required awareness encountered it at their workstations, within their offices, in those structured professional settings designed to contain reactions until they could be properly controlled.

The containment held for about four minutes.

The initial reader in the Department of Health and Social Care remained motionless for a brief instant. Then, she grabbed her phone and dialed her director. Upon his response, she offered no words of her own. Instead, she recited the subscription tier costs to him, one by one, deliberately and unhurriedly.

He promised a callback, yet two full hours passed without one.

By the moment senior health ministers gathered, the announcement had undergone thorough analysis, sharing, capture in screenshots, and debate among roughly forty million residents of Britain. Social platforms had achieved in mere forty minutes what traditional media outlets might have needed days to achieve. The populace wasn't holding out for an authoritative reply. They had already crafted their own.

The atmosphere in the meeting chamber carried that specific hush that descends on grave individuals when they grasp that the issue before them exceeds the grasp of their current paradigms.

Someone had produced a printed copy of the announcement. Spanning twelve pages. The pile rested at the table's midpoint, untouched, since all attendees had already reviewed it thrice on their personal gadgets prior to entry.

The opening inquiry in that space bypassed the scientific aspects. It skipped regulatory authority. It ignored the international ramifications of a private entity declaring extraterrestrial medical experiments.

It proved far more straightforward.

A voice inquired about the implications for the NHS.

The ensuing quiet stretched sufficiently to serve as its own reply.

The NHS stood as Britain's nearest equivalent to a hallowed entity. It had endured conflicts, arguments over privatization, budgetary shortfalls, and generations of partisan battles from all sides. It embodied more than mere medical care. It symbolized a shared vow that British society extended to itself regarding the nation's desired identity. Care would be provided. Irrespective of wealth. Irrespective of situation. The government would stand ready.

Nova Medical Nanites didn't assault that vow. They rendered it insignificant.

Not due to shortcomings in the NHS. Rather, because the capabilities outlined by Nova Technologies functioned on a plane unattainable by any governmental body, regardless of its funding or noble aims. A $99 monthly fee covering infectious ailments and preliminary illness identification. A $299 level eradicating cancer. The NHS had battled cancer using every tool of contemporary medicine for years. Nova Technologies proposed to wipe it out for under the cost of a typical fitness club subscription.

The individual who posed the NHS question glanced across the table and murmured softly that utmost caution was essential in their public statements over the coming forty-eight hours. For any declarations would be judged against that pricing model for years to come.

All nodded in agreement. Yet none possessed an alternative to propose.

The regulatory issue emerged swiftly and resolved itself nearly as promptly.

Britain's drug oversight body held authority over approvals within the United Kingdom. It lacked power over events at an extraterrestrial site. The clinical study declared by Nova Technologies unfolded in a venue beyond any pre-established oversight structure. No clause in British legislation existed for assessing the validity of a treatment performed in space.

The legal experts conveyed this evaluation using the precise phrasing typical of those skilled in delivering unwelcome verdicts with poise. They pointed out that UK residents could lawfully journey abroad for medical studies. They highlighted the extraterrestrial setting's creation of oversight uncertainty demanding brand-new legal constructs. They emphasized that forging such constructs would demand far more than ninety days.

What they omitted, though all comprehended, was that once any fresh oversight system was conceived, argued, enacted, and enacted, the study would have commenced or concluded. Laws targeting a finished experiment amounted not to oversight but to mere performance.

A minister proposed concentrating on controllable elements over unreachable ones. The group consented. Attention then shifted to whether dispatching official monitors constituted an engagement signaling validation or a duty to science conveying only a pledge for direct knowledge.

The argument over that nuance endured longer than participants later cared to confess.

***

Brussels absorbed the news at that same decorous morning hour and responded with the intricate dynamics arising from twenty-seven nations striving to forge a unified reaction to an unprecedented development.

Preliminary discussions among health leaders from member nations yielded a landscape of clashing impulses mirroring the union's own variety. Nations strained by elder demographics and insufficient budgets viewed the nanite news via a prism of eager desperation blended with deep worries over availability. States boasting robust local drug sectors perceived it as an economic peril. Countries with established research legacies saw it as a remarkable prospect. Territories emphasizing national independence regarded it as a warning to establishments.

Aligning twenty-seven such perspectives into one clear view within ninety days posed the dilemma.

The European Medicines Agency confronted an unprecedented role. Its role involved appraising and sanctioning drugs and devices for EU application. The announcement portrayed Nova Medical Nanites as neither drug nor device. They constituted exact medical systems. This differentiation wasn't mere wordplay. It formed a foundational claim that current sanction processes lacked a slot for the described innovation.

An in-house review determined that appraising Nova Medical Nanites via standard EMA methods would resemble judging a spacecraft by bicycle rules. The methods held no fault. They merely suited different purposes than the task at hand.

This finding reached health leaders in member nations alongside a suggestion that the EU must craft novel assessment systems prior to any substantive oversight interaction with the tech.

Numerous ministers inquired about the timeframe, and the reply fell poorly.

Public demands in Europe manifested distinct from Britain's swift, vocal surge via social networks and citizen outreach to officials. In Europe, pressure flowed through the specialized pathways honed by continental civil engagement over years. Groups advocating for patients. Foundations for medical studies. Coalitions for disability rights. Bodies representing those enduring the ailments specified in Nova Technologies' reveal.

These groups bypassed awaiting state replies. They released their positions inside twenty-four hours. Their wording balanced restraint where required and clarity where essential.

A declaration from a continent-wide cancer patient support group observed that the news outlined the eradication of every identified cancer type. It urged member governments to reflect on how their reactions reflected their values. It issued no commands. None were necessary. The suggestion endured across translations into twenty-three languages with undiminished potency.

Foundations for neurological ailments issued comparable declarations. Groups for immune system disorders. Networks for uncommon illnesses, where sufferers had long maneuvered through care systems that alleviated but didn't cure. Each missive originated from varied groups and converged on the core issue from unique directions.

European administrations faced calls to address a matter touching millions of their people's lives directly. The character of that address would linger in memory.

Internal EU deliberations on dispatching monitors sparked truly challenging disputes without simple answers.

Opposition to involvement hinged on preserving institutional trust. Dispatching envoys to a study beyond oversight realms, run by a firm that had declared refusal of oversight as a prerequisite for any sanction, might signal unspoken approval. The EU's sanction power stemmed in part from its reliability. Appearing to interact with mechanisms wholly external to its structure questioned the framework's limits.

The argument for involvement was more direct and tougher to refute.

The innovation existed. The study proceeded irrespective of EU involvement. Residents of EU nations would face consequences from this technology's outcomes. Lacking direct data, independent checks, or an official EU footprint during a pivotal historical event marked a lapse in duty that no defense of sanction integrity could excuse.

A prominent voice in the EU's health strategy framework stated it plainly in a subsequent session. She noted that establishments served the populace. Europe's citizens held immediate stakes in Nova Technologies' disclosure. An establishment valuing its protocols above the needs of those it aids had mistaken its role for its survival.

The chamber paused without instant retort.

Then a voice remarked that it might be the truest observation across these gatherings, and they ought to vote before rebuttals arose.

**

Both Britain and the EU reached identical conclusions via varied paths and paces.

Observers would be dispatched.

Not to fulfill Nova Technologies' wishes. Not to alter the study's conduct, schedule, or conditions already established by Nova Technologies. But to avoid mere spectatorship from afar as a transformative force remade their communities without their presence.

The announcements verifying involvement underwent multiple drafts and revisions prior to issuance. Each term underwent scrutiny for hints of sanction acknowledgment, institutional support, and strategic stance.

The ultimate editions conveyed the bare minimum while affirming the essentials.